TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
VRTX

Vertex Pharmaceuticals Inc

Healthcare · Biotechnology

503.50$ -0.2% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Cash Flow

Vertex Pharmaceuticals Inc (VRTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 1,125 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow VRTX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
66 145 266 182 170 228 253 322 381 315 325 464 335 446 816 1,039 908 492 921 -200 927 995 956 1,140 956 1,078 900 1,134 1,268 235 1,307 -3,754 1,370 585 819 1,073 1,241 498 1,428 1,125 4,293
15 15 15 15 15 16 16 18 19 19 27 28 26 26 27 27 27 29 29 31 32 34 36 37 37 38 39 41 42 59 54 54 53 47 48 52 54 56 56 57 222
61 59 69 73 74 75 78 82 86 79 94 90 85 92 116 117 100 97 115 105 103 119 130 114 136 112 122 119 131 209 192 154 185 168 166 167 195 158 166 170 689
57 66 66 82 567 82 -7.9 36 154 203 91 98 78 114 127 133 137 124 114 -133 114 110 128 54 107 158 142 108 – – – – – – – – – – – – –
33 42 -66 50 -2.7 34 13 61 80 83 -62 83 135 -222 -22 179 96 -307 16 -164 -92 135 -33 384 81 -91 139 245 189 -839 129 -241 158 -560 -269 -132 150 -948 245 -115 -669
14 15 11 18 188 43 29 30 21 16 18 16 24 17 19 18 175 48 71 50 52 62 64 53 54 34 42 60 41 58 248 77 68 93 41 146 102 149 133 112 497
35 230 -158 -96 -162 -21 4.9 -116 -50 -41 -39 -50 -249 -897 32 72 -248 244 -74 -80 -53 -134 -51 -62 -384 176 -1,834 -304 -118 -887 -2,136 -464 -348 -822 -56 -485 -117 -288 -432 -46 -883
0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 3.4 7.9 – 1.0 – 9.0 5.8 – – 151 3.6 – – 57 34 – 37 – – 59 15 – – – – – – – – – – – –
17 17 11 137 150 47 -10 -105 -92 -143 -100 -56 -0.1 -36 -300 -3.1 -108 -131 -425 -3.6 -632 -368 -118 -4.4 -48 -2.1 -133 -28 -117 -150 -131 -320 -308 -418 -426 -392 -1,071 -131 -565 -474 -2,241
-3.9 2.1 -305 -6.1 1.4 25 0.4 -4.9 -2.3 -0.3 -11 1.0 -11 -2.8 -5.3 -11 -8.8 -3.5 -8.6 -2.3 -11 -2.5 -13 -13 -50 -10 -11 -11 – – – – -5.4 -1.3 -1.3 -1.3 -1.4 -1.4 – – –
14 94 -290 132 153 73 79 -51 2.1 -101 -42 -13 20 161 -359 120 -141 -125 -519 34 -657 -336 -95 48 -60 40 -295 17 -165 -120 -358 -359 -388 -391 -680 -349 -1,155 -77 -539 -427 -2,197
114 464 -180 219 162 280 338 148 333 171 243 400 103 -284 481 1,234 525 628 324 -242 209 520 804 1,100 473 1,335 -1,216 858 963 -744 -1,203 -4,578 657 -676 113 297 -34 140 417 649 1,172
52 130 255 164 142 185 223 292 360 299 307 447 310 429 796 1,021 733 444 850 -250 875 933 893 1,087 901 1,045 858 1,075 1,228 177 1,058 -3,830 1,302 492 778 927 1,140 349 1,295 1,013 3,796

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?